Co-Diagnostics (NASDAQ:CODX) CEO Discusses Mosquito Control Test for Deadly EEE Virus New York City, Dec. 19, 2019 (GLOBE NEWSWIRE) -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular diagnostic tests that has been...

Co-Diagnostics’ (NASDAQ: CODX) Mosquito Control Products Now Includes Test for Deadly EEE Virus New York City, Dec. 11, 2019 (GLOBE NEWSWIRE) -- News yesterday from BDA International client Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular...

Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from...

Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products Salt Lake City, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...